Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Addressing the most neglected diseases through an open research model: The discovery of fenarimols as novel drug candidates for eumycetoma.

Lim W, Melse Y, Konings M, Phat Duong H, Eadie K, Laleu B, Perry B, Todd MH, Ioset JR, van de Sande WWJ.

PLoS Negl Trop Dis. 2018 Apr 26;12(4):e0006437. doi: 10.1371/journal.pntd.0006437. eCollection 2018 Apr.

2.

Chitinase Induction Prior to Caspofungin Treatment of Experimental Invasive Aspergillosis in Neutropenic Rats Does Not Enhance Survival.

Refos JM, Vonk AG, Ten Kate MT, Verbrugh HA, Bakker-Woudenberg IAJM, van de Sande WWJ.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e00960-17. doi: 10.1128/AAC.00960-17. Print 2018 Jan.

PMID:
29084744
3.

Amphotericin B and terbinafine but not the azoles prolong survival in Galleria mellonella larvae infected with Madurella mycetomatis.

Kloezen W, Parel F, Brüggemann R, Asouit K, Helvert-van Poppel M, Fahal A, Mouton J, van de Sande W.

Med Mycol. 2018 Jun 1;56(4):469-478. doi: 10.1093/mmy/myx064.

PMID:
28992315
4.

Closing the mycetoma knowledge gap.

van de Sande W, Fahal A, Ahmed SA, Serrano JA, Bonifaz A, Zijlstra E; eumycetoma working group.

Med Mycol. 2018 Apr 1;56(suppl_1):153-164. doi: 10.1093/mmy/myx061.

PMID:
28992217
5.

Mycetoma laboratory diagnosis: Review article.

Ahmed AA, van de Sande W, Fahal AH.

PLoS Negl Trop Dis. 2017 Aug 24;11(8):e0005638. doi: 10.1371/journal.pntd.0005638. eCollection 2017 Aug. Review.

6.

Addition of 17-(allylamino)-17-demethoxygeldanamycin to a suboptimal caspofungin treatment regimen in neutropenic rats with invasive pulmonary aspergillosis delays the time to death but does not enhance the overall therapeutic efficacy.

Refos JM, Vonk AG, Ten Kate MT, Eadie K, Verbrugh HA, Bakker-Woudenberg IAJM, van de Sande WWJ.

PLoS One. 2017 Jul 24;12(7):e0180961. doi: 10.1371/journal.pone.0180961. eCollection 2017.

7.

Combining two antifungal agents does not enhance survival of Galleria mellonella larvae infected with Madurella mycetomatis.

Eadie K, Parel F, Helvert-van Poppel M, Fahal A, van de Sande W.

Trop Med Int Health. 2017 Jun;22(6):696-702. doi: 10.1111/tmi.12871. Epub 2017 May 2.

8.

Detection of (1→3)-β-d-Glucan in Eumycetoma Patients.

Fahal AH, Finkelman MA, Zhang Y, van de Sande WW.

J Clin Microbiol. 2016 Oct;54(10):2614-7. doi: 10.1128/JCM.01478-16. Epub 2016 Jul 20.

9.

Genome Sequence of Madurella mycetomatis mm55, Isolated from a Human Mycetoma Case in Sudan.

Smit S, Derks MF, Bervoets S, Fahal A, van Leeuwen W, van Belkum A, van de Sande WW.

Genome Announc. 2016 May 26;4(3). pii: e00418-16. doi: 10.1128/genomeA.00418-16.

10.

Phaeoacremonium sphinctrophorum as a Novel Agent of Eumycetoma.

Bustamante B, Ahmed SA, De Hoog GS, Seas C, Van De Sande WW.

JAMA Dermatol. 2016 Sep 1;152(9):1063-5. doi: 10.1001/jamadermatol.2016.1310. No abstract available.

PMID:
27224667
11.

Decreased Cell Wall Galactosaminogalactan in Aspergillus nidulans Mediates Dysregulated Inflammation in the Chronic Granulomatous Disease Host.

Henriet SS, van de Sande WW, Lee MJ, Simonetti E, Momany M, Verweij PE, Rijs AJ, Ferwerda G, Sheppard DC, de Jonge MI, Warris A.

J Interferon Cytokine Res. 2016 Aug;36(8):488-98. doi: 10.1089/jir.2015.0095. Epub 2016 May 4.

PMID:
27142572
12.

Mycetoma: A Long Journey from Neglect.

Zijlstra EE, van de Sande WW, Fahal AH.

PLoS Negl Trop Dis. 2016 Jan 21;10(1):e0004244. doi: 10.1371/journal.pntd.0004244. eCollection 2016 Jan. No abstract available.

13.

Mycetoma: a unique neglected tropical disease.

Zijlstra EE, van de Sande WWJ, Welsh O, Mahgoub ES, Goodfellow M, Fahal AH.

Lancet Infect Dis. 2016 Jan;16(1):100-112. doi: 10.1016/S1473-3099(15)00359-X. Review.

PMID:
26738840
14.

A Polymorphism in the Chitotriosidase Gene Associated with Risk of Mycetoma Due to Madurella mycetomatis Mycetoma--A Retrospective Study.

Verwer PE, Notenboom CC, Eadie K, Fahal AH, Verbrugh HA, van de Sande WW.

PLoS Negl Trop Dis. 2015 Sep 2;9(9):e0004061. doi: 10.1371/journal.pntd.0004061. eCollection 2015.

15.

Application of Isothermal Amplification Techniques for Identification of Madurella mycetomatis, the Prevalent Agent of Human Mycetoma.

Ahmed SA, van de Sande WW, Desnos-Ollivier M, Fahal AH, Mhmoud NA, de Hoog GS.

J Clin Microbiol. 2015 Oct;53(10):3280-5. doi: 10.1128/JCM.01544-15. Epub 2015 Aug 5.

16.

A Madurella mycetomatis Grain Model in Galleria mellonella Larvae.

Kloezen W, van Helvert-van Poppel M, Fahal AH, van de Sande WW.

PLoS Negl Trop Dis. 2015 Jul 14;9(7):e0003926. doi: 10.1371/journal.pntd.0003926. eCollection 2015.

17.

Amphotericin B but not itraconazole is able to prevent grain formation in experimental Madurella mycetomatis mycetoma in mice.

van de Sande WW, van Vianen W, ten Kate M, Fahal A, Bakker-Woudenberg I.

Br J Dermatol. 2015 Dec;173(6):1561-2. doi: 10.1111/bjd.14025. Epub 2015 Oct 23. No abstract available.

PMID:
26150103
18.

The in vitro antifungal activity of sudanese medicinal plants against Madurella mycetomatis, the eumycetoma major causative agent.

Elfadil H, Fahal A, Kloezen W, Ahmed EM, van de Sande W.

PLoS Negl Trop Dis. 2015 Mar 13;9(3):e0003488. doi: 10.1371/journal.pntd.0003488. eCollection 2015 Mar.

19.

Revision of agents of black-grain eumycetoma in the order Pleosporales.

Ahmed SA, van de Sande WW, Stevens DA, Fahal A, van Diepeningen AD, Menken SB, de Hoog GS.

Persoonia. 2014 Dec;33:141-54. doi: 10.3767/003158514X684744. Epub 2014 Sep 16.

20.

Eumycetoma and actinomycetoma--an update on causative agents, epidemiology, pathogenesis, diagnostics and therapy.

Nenoff P, van de Sande WW, Fahal AH, Reinel D, Schöfer H.

J Eur Acad Dermatol Venereol. 2015 Oct;29(10):1873-83. doi: 10.1111/jdv.13008. Epub 2015 Feb 27. Review.

PMID:
25726758
21.

In vitro antifungal susceptibility of coelomycete agents of black grain eumycetoma to eight antifungals.

Ahmed SA, de Hoog GS, Stevens DA, Fahal AH, van de Sande WW.

Med Mycol. 2015 Apr;53(3):295-301. doi: 10.1093/mmy/myu098. Epub 2015 Jan 28.

PMID:
25631481
22.

Validation of a new Aspergillus real-time PCR assay for direct detection of Aspergillus and azole resistance of Aspergillus fumigatus on bronchoalveolar lavage fluid.

Chong GL, van de Sande WW, Dingemans GJ, Gaajetaan GR, Vonk AG, Hayette MP, van Tegelen DW, Simons GF, Rijnders BJ.

J Clin Microbiol. 2015 Mar;53(3):868-74. doi: 10.1128/JCM.03216-14. Epub 2015 Jan 7.

23.

In vitro interaction of currently used azoles with terbinafine against Madurella mycetomatis.

Ahmed SA, Kloezen W, Fahal AH, de Hoog GS, van de Sande WW.

Antimicrob Agents Chemother. 2015 Feb;59(2):1373-4. doi: 10.1128/AAC.04487-14. Epub 2014 Dec 8. No abstract available.

24.

Rapid identification of black grain eumycetoma causative agents using rolling circle amplification.

Ahmed SA, van den Ende BH, Fahal AH, van de Sande WW, de Hoog GS.

PLoS Negl Trop Dis. 2014 Dec 4;8(12):e3368. doi: 10.1371/journal.pntd.0003368. eCollection 2014 Dec.

25.

In vitro activity of antiseptic solutions against Madurella mycetomatis: implications for eumycetoma management.

Eadie K, Fahal A, van de Sande WW.

Br J Dermatol. 2015 Jun;172(6):1657-9. doi: 10.1111/bjd.13570. Epub 2015 Apr 29. No abstract available.

PMID:
25429729
26.

Mapping the potential risk of mycetoma infection in Sudan and South Sudan using ecological niche modeling.

Samy AM, van de Sande WW, Fahal AH, Peterson AT.

PLoS Negl Trop Dis. 2014 Oct 16;8(10):e3250. doi: 10.1371/journal.pntd.0003250. eCollection 2014 Oct.

27.

Merits and pitfalls of currently used diagnostic tools in mycetoma.

van de Sande WW, Fahal AH, Goodfellow M, Mahgoub el S, Welsh O, Zijlstra EE.

PLoS Negl Trop Dis. 2014 Jul 3;8(7):e2918. doi: 10.1371/journal.pntd.0002918. eCollection 2014 Jul. Review.

28.

Roussoella percutanea, a novel opportunistic pathogen causing subcutaneous mycoses.

Ahmed SA, Stevens DA, van de Sande WW, Meis JF, de Hoog GS.

Med Mycol. 2014 Oct;52(7):689-98. doi: 10.1093/mmy/myu035. Epub 2014 Jun 25.

PMID:
24969729
29.

Madurella mycetomatis is highly susceptible to ravuconazole.

Ahmed SA, Kloezen W, Duncanson F, Zijlstra EE, de Hoog GS, Fahal AH, van de Sande WW.

PLoS Negl Trop Dis. 2014 Jun 19;8(6):e2942. doi: 10.1371/journal.pntd.0002942. eCollection 2014 Jun.

30.

The combination of amoxicillin-clavulanic acid and ketoconazole in the treatment of Madurella mycetomatis eumycetoma and Staphylococcus aureus co-infection.

Mhmoud NA, Fahal AH, Mahgoub el S, van de Sande WW.

PLoS Negl Trop Dis. 2014 Jun 19;8(6):e2959. doi: 10.1371/journal.pntd.0002959. eCollection 2014 Jun.

31.

Active matrix metalloprotease-9 is associated with the collagen capsule surrounding the Madurella mycetomatis grain in mycetoma.

Geneugelijk K, Kloezen W, Fahal AH, van de Sande WW.

PLoS Negl Trop Dis. 2014 Mar 27;8(3):e2754. doi: 10.1371/journal.pntd.0002754. eCollection 2014 Mar.

32.

The mycetoma knowledge gap: identification of research priorities.

van de Sande WW, Maghoub el S, Fahal AH, Goodfellow M, Welsh O, Zijlstra E.

PLoS Negl Trop Dis. 2014 Mar 27;8(3):e2667. doi: 10.1371/journal.pntd.0002667. eCollection 2014 Mar. Review.

33.

Global burden of human mycetoma: a systematic review and meta-analysis.

van de Sande WW.

PLoS Negl Trop Dis. 2013 Nov 7;7(11):e2550. doi: 10.1371/journal.pntd.0002550. eCollection 2013 Nov. Review.

34.

Double-stranded RNA mycovirus infection of Aspergillus fumigatus is not dependent on the genetic make-up of the host.

Refos JM, Vonk AG, Eadie K, Lo-Ten-Foe JR, Verbrugh HA, van Diepeningen AD, van de Sande WW.

PLoS One. 2013 Oct 22;8(10):e77381. doi: 10.1371/journal.pone.0077381. eCollection 2013.

35.

Evidence supporting a role for mammalian chitinases in efficacy of caspofungin against experimental aspergillosis in immunocompromised rats.

Verwer PE, ten Kate MT, Falcone FH, Morroll S, Verbrugh HA, Bakker-Woudenberg IA, van de Sande WW.

PLoS One. 2013 Oct 14;8(10):e75848. doi: 10.1371/journal.pone.0075848. eCollection 2013.

36.

Discrimination of Aspergillus lentulus from Aspergillus fumigatus by Raman spectroscopy and MALDI-TOF MS.

Verwer PE, van Leeuwen WB, Girard V, Monnin V, van Belkum A, Staab JF, Verbrugh HA, Bakker-Woudenberg IA, van de Sande WW.

Eur J Clin Microbiol Infect Dis. 2014 Feb;33(2):245-51. doi: 10.1007/s10096-013-1951-4. Epub 2013 Sep 13.

PMID:
24030717
37.

Association of eumycetoma and schistosomiasis.

van Hellemond JJ, Vonk AG, de Vogel C, Koelewijn R, Vaessen N, Fahal AH, van Belkum A, van de Sande WW.

PLoS Negl Trop Dis. 2013 May 23;7(5):e2241. doi: 10.1371/journal.pntd.0002241. Print 2013.

38.

Phylogenetic findings suggest possible new habitat and routes of infection of human eumyctoma.

de Hoog GS, Ahmed SA, Najafzadeh MJ, Sutton DA, Keisari MS, Fahal AH, Eberhardt U, Verkleij GJ, Xin L, Stielow B, van de Sande WW.

PLoS Negl Trop Dis. 2013 May 16;7(5):e2229. doi: 10.1371/journal.pntd.0002229. Print 2013.

39.

Mycetoma caused by Madurella mycetomatis: a completely neglected medico-social dilemma.

van Belkum A, Fahal A, van de Sande WW.

Adv Exp Med Biol. 2013;764:179-89. Review.

PMID:
23654067
40.

Peripheral blood mononuclear cells of mycetoma patients react differently to Madurella mycetomatis antigens than healthy endemic controls.

Elagab EA, Mukhtar MM, Fahal AH, van de Sande WW.

PLoS Negl Trop Dis. 2013 Apr 25;7(4):e2081. doi: 10.1371/journal.pntd.0002081. Print 2013. No abstract available.

41.

A histopathological exploration of the Madurella mycetomatis grain.

Ibrahim AI, El Hassan AM, Fahal A, van de Sande WW.

PLoS One. 2013;8(3):e57774. doi: 10.1371/journal.pone.0057774. Epub 2013 Mar 6.

42.

The association between the interleukin-10 cytokine and CC chemokine ligand 5 polymorphisms and mycetoma granuloma formation.

Mhmoud NA, Fahal AH, van de Sande WW.

Med Mycol. 2013 Jul;51(5):527-33. doi: 10.3109/13693786.2012.745201. Epub 2012 Dec 4.

PMID:
23210681
43.

Diagnosis of active tuberculosis by e-nose analysis of exhaled air.

Bruins M, Rahim Z, Bos A, van de Sande WW, Endtz HP, van Belkum A.

Tuberculosis (Edinb). 2013 Mar;93(2):232-8. doi: 10.1016/j.tube.2012.10.002. Epub 2012 Nov 3.

PMID:
23127779
44.

In vitro antifungal activity of isavuconazole against Madurella mycetomatis.

Kloezen W, Meis JF, Curfs-Breuker I, Fahal AH, van de Sande WW.

Antimicrob Agents Chemother. 2012 Nov;56(11):6054-6. doi: 10.1128/AAC.01170-12. Epub 2012 Sep 10.

45.

Nocardia nova mycetoma over forehead in a lepromatous leprosy patient.

Dhingra M, Kaistha N, Bansal N, Solanki LS, Chander J, Thami GP, van de Sande WW.

Dermatol Online J. 2012 Jul 15;18(7):3.

PMID:
22863625
46.

Pleurostomophora ochracea, a novel agent of human eumycetoma with yellow grains.

Mhmoud NA, Ahmed SA, Fahal AH, de Hoog GS, Gerrits van den Ende AH, van de Sande WW.

J Clin Microbiol. 2012 Sep;50(9):2987-94. doi: 10.1128/JCM.01470-12. Epub 2012 Jul 3.

47.

CD4+ T-lymphocytopenia in HIV-negative tuberculosis patients in Sudan.

Mhmoud NA, Fahal AH, van de Sande WW.

J Infect. 2012 Oct;65(4):370-2. doi: 10.1016/j.jinf.2012.06.003. Epub 2012 Jun 20. No abstract available.

PMID:
22728173
48.
49.

Secondary peritonitis caused by Streptomyces viridis.

Datta P, Arora S, Jain R, Chander J, van de Sande W.

J Clin Microbiol. 2012 May;50(5):1813-4. doi: 10.1128/JCM.06045-11. Epub 2012 Feb 15.

50.

New species of Madurella, causative agents of black-grain mycetoma.

de Hoog GS, van Diepeningen AD, Mahgoub el-S, van de Sande WW.

J Clin Microbiol. 2012 Mar;50(3):988-94. doi: 10.1128/JCM.05477-11. Epub 2012 Jan 11.

Supplemental Content

Loading ...
Support Center